Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies
JANUARY 21, 2020 MIAMI, Fla., January 21, 2020 – Bio-Techne, Fresenius Kabi, and Wilson Wolf have formed a new joint venture company to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize... Read more